AAPG Ascentage Pharma Corp Sotuvning yalpi rentabelligi

Ascentage Pharma Group International (AAPG) kompaniyasining rasmiy ramzlari

Ascentage Pharma Group o'zining leykozga qarshi dori vositalarining muvaffaqiyati va Takeda bilan hamkorligiga tayangan holda, maqsadli onkologiya rivojlantirishida yetakchilik qilmoqda. Xitoyda savdoning kengayishi moliyaviy poydevorni yaratmoqda, bu esa qisman tadqiqot va ishlanmalar (R&D) xarajatlari bilan qoplanadi. O'sish yangi terapiyalarning tasdiqlanishi va investitsiyalar hisobiga ta'minlanmoqda. Ushbu GURU.Markets grafigida ko'rsatilgan joriy yalpi foyda 83.20 orqali eng so'nggi metrika darajasini ifodalaydi.

Ascentage Pharma Group (AAPG) - Yalpi marja 25.01.2025dan 19.11.2026gacha

Ascentage Pharma Group International (AAPG) moliyaviy va bozor koʻrsatkichlari kesimi

- aksiyalar qiymati va narxlar bo'yicha konsensus prognoz:
Kompaniyaning jamlanma tahlili:Ascentage Pharma Group International (AAPG)
Ascentage Pharma original mahsuloti

Aktivlar samaradorligining qiyosiy tahlili uchun investorga yalpi foyda marginini tushum va sotilgan tovarlarning bevosita xarajatlari orasidagi farq sifatida baholash juda muhimdir, chunki bu biznesning foyda keltirish qobiliyatini belgilaydi. Ascentage Pharma Group (AAPG) kompaniyasida ushbu ko'rsatkich biomateriallarni utilizatsiya qilishga oid qat'iy tibbiy qoidalarni hisobga olgan holda onkologik dori vositalarini ishlab chiqish xarajatlarini aks ettiradi, bu esa investorlarga GURU.Markets platformasidagi joriy yalpi foyda margini darajasi orqali kompaniyaning moliyaviy barqarorligini kuzatish imkonini beradi.

Asosiy raqobatchilar

Yalpi foyda marjasi BeiGene Ltd. (ONC)|Yalpi foyda bo'yicha rentabellik HALO|Yalpi rentabellik RVMD|Yalpi marja CGON|UroGen Pharma - Sotuvning yalpi rentabelligi|Bicara Therapeutics - Yalpi foyda bo'yicha rentabellik|Yalpi marja Personalis Inc PSNL|Erasca Oncology - Yalpi marja|Yalpi foyda normasi DCTH (Delcath Corp)|YMAB: Yalpi marja|AURA - Yalpi foyda bo'yicha sotuv rentabelligi|CADL (Candel Therapeutics Inc.) - Yalpi marja|Sotuvning yalpi rentabelligi ARAY (Accuray)|Yalpi foyda bo'yicha rentabellik SLS (SELLAS Life Sciences Group, Inc.)|ACTU - Yalpi foyda marjasi|Yalpi rentabellik Citius Oncology, Inc. CTOR|HURA - Yalpi foyda bo'yicha rentabellik|protaratx.com - Yalpi marja|FATE - Yalpi marja|WHWK: Yalpi marja|TScan Therapeutics (TCRX) - Yalpi marja|Yalpi rentabellik Champions Oncology|Yalpi rentabellik XBIT|Yalpi marja CVM|Yalpi foyda bo'yicha rentabellik OS Therapies Inc. OSTX|Yalpi rentabellik Radiopharm Theranostics Limited RADX|artivabio.com (ARTV) - Yalpi foyda marjasi|ANL - Yalpi rentabellik|Yalpi foyda marjasi verupharma.com|TPST: Yalpi marja|XLO - Yalpi foyda bo'yicha sotuv rentabelligi|Yalpi rentabellik Renovaro|Yalpi marja muraloncology.com|Yalpi marja KAPA|Yalpi foyda bo'yicha sotuv rentabelligi OnKure Therapeutics, Inc.|Yalpi marja GDTC (w2.cytomed.sg)|CRIS - Yalpi foyda bo'yicha rentabellik|Apollomics - Yalpi marja|Tharimmune Corp (THAR) - Yalpi foyda bo'yicha rentabellik|ADVB: Yalpi marja|Yalpi foyda bo'yicha rentabellik Genprex|CLDI (Calidi Biotherapeutics, Inc.) - Yalpi marja|Sotuvning yalpi rentabelligi SBFM (Sunshine Biopharma)|Yalpi rentabellik Xenetic Bio (XBIO)|Yalpi rentabellik SLRX (Salarius Pharma)|Kitov Pharma - Yalpi foyda bo'yicha rentabellik|American Oncology Network (AONC) - Yalpi foyda marjasi|BeiGene - Yalpi marja|Checkpoint Therapeutics, Inc. (CKPT) - Yalpi foyda bo'yicha rentabellik|ELEV (Elevation Oncology, Inc.) - Yalpi foyda bo'yicha rentabellik|iCAD Inc. - Yalpi foyda normasi|Yalpi foyda bo'yicha rentabellik IKNA|Yalpi marja notablelabs.com|Yalpi foyda bo'yicha rentabellik VIRX (Viracta Therapeutics Inc.)|MOR - Yalpi foyda marjasi|Yalpi rentabellik NAYA Biosciences NAYA|AAPGV - Yalpi foyda bo'yicha rentabellik